CAS 2189684-44-2

Lenacapavir

CAS: 2189684-44-2

Formel: C₃₉H₃₂ClF₁₀N₇O₅S₂

Molekulargewicht: 968.28

Ref: 4Z-L-205001

Lenacapavir

CAS: 2189684-44-2

Lenacapavir

Reinheit: ≥98%

Molekulargewicht: 968.28g/mol

Ref: 54-BUP09401

Lenacapavir

CAS: 2189684-44-2

Formel: C₃₉H₃₂ClF₁₀N₇O₅S₂

Farbe und Form: Neat

Molekulargewicht: 968.29

Ref: TR-L329070

Lenacapavir

CAS: 2189684-44-2

Lenacapavir (GS-6207) is the first HIV-1 capsid inhibitor approved by the U.S. Food and Drug Administration, the European Medicines Agency, and Health Canada for the treatment of MDR HIV-1 infection.Cost-effective and quality-assured.

Formel: C₃₉H₃₂ClF₁₀N₇O₅S₂

Reinheit: 99.61% - 99.87%

Farbe und Form: Solid

Molekulargewicht: 968.28

Ref: TM-T11465

Lenacapavir

CAS: 2189684-44-2

Lenacapavir is a capsid inhibitor with a mode of action that interferes with the HIV capsid protein, disrupting multiple stages of the viral lifecycle. It is used for treating multidrug-resistant HIV infections.

Formel: C₃₉H₃₂ClF₁₀N₇O₅S₂

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 968.28 g/mol

Ref: 3D-AL180739